Newer generation antidepressant drugs (ADs) are widely used as the first line of treatment
for major depressive disorders and are considered to be safer than tricyclic agents. In this …

Restless legs syndrome (RLS) is a common disorder. The population prevalence is 1.5% to
2.7% in a subgroup of patients having more severe RLS with symptoms occurring 2 or more …

The objective of the current review was to update the previous evidence‐based medicine
review of treatments for restless legs syndrome published in 2008. All randomized …

Restless legs syndrome is commonly co-morbid with medical conditions that are treated with
antidepressant medications, such as depression, anxiety, fibromyalgia, and chronic …

Psychiatric disorders and sleep problems are both common, with an estimated prevalence in
12 months of about 30% for any of the Diagnostic and Statistical Manual of Mental …

Restless legs syndrome (RLS)/Willis-Ekbom disease (WED) is common during pregnancy,
affecting approximately one in five pregnant women in Western countries. Many report …

Background Since the publication of the first E uropean F ederation of N eurological S
ocieties (EFNS) guidelines in 2005 on the management of restless legs syndrome (RLS; …

Restless legs syndrome (RLS)/Willis-Ekbom disease (WED) is a common disorder,
occurring at least twice a week and causing at least moderate distress in 1.5% to 2.7% of the …

The connection between smoking and Obstructive sleep apnea (OSA) is not yet clear. There
are studies that have confirmed the effect of smoking on sleep disordered breathing …

Abstract Purpose of Review: This article provides an update on six sleep-related movement
disorders: restless legs syndrome (RLS), periodic limb movement disorder, sleep-related leg …